Agreement will focus on designing and deploying best practice enhanced recovery protocols across therapeutic areas in 11 Georgia-based hospitals PARSIPPANY, N.J. and ATLANTA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- WellStar Health System , the largest health system in Georgia, and Pacira Pharmaceuticals,
Continuous quality improvement project aims to optimize patient outcomes after hernia repair PARSIPPANY, N.J. and KNOXVILLE, Tenn. , Feb. 27, 2018 (GLOBE NEWSWIRE) -- To improve patient outcomes and combat a segment of the national opioid epidemic, The University of Tennessee Medical Center and
Data Presented at Annual Meetings of Leading Regional Anesthesia Societies Demonstrate Analgesia for Up to 72 Hours and High Patient Satisfaction PARSIPPANY, N.J. --(BUSINESS WIRE)--May. 6, 2013-- Pacira Pharmaceuticals, Inc . (NASDAQ: PCRX) today announced findings from two new studies supporting
Data Presented at 2014 Annual Meeting of the American Academy of Orthopedic Surgeons Show EXPAREL Improved Pain Scores , Lowered Opioid Consumption, and Reduced Hospital Stays, Falls and Overall Costs PARSIPPANY, N.J. & NEW ORLEANS --(BUSINESS WIRE)--Mar.
Collaboration will develop and standardize evidence-based, low-opioid strategies across Trinity Health's 22 states to benefit people and communities PARSIPPANY, N. J. and LIVONIA, Mich., March 16, 2017 (GLOBE NEWSWIRE) -- Trinity Health , one of the largest hospital systems in the nation, and
TAMPA, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that the United States Court of Appeals for the Third Circuit affirmed the District Court’s dismissal of the Company’s suit against the American Society of Anesthesiologists (ASA) and various
Data Presented at 7 th Annual Marshall Steele Orthopedic & Spine Summit PARSIPPANY, N.J. --(BUSINESS WIRE)--Sep. 19, 2013-- Pacira Pharmaceuticals, Inc . (NASDAQ:PCRX) today announced results from a 200-patient study evaluating the benefits of EXPAREL ® (bupivacaine liposome injectable
SkyePharma Inc. announced today that the company has changed its name to Pacira Pharmaceuticals, Inc. The name change reflects Pacira’s transformation from a former business unit of SkyePharma PLC to an independent, private company with existing commercial products, a strong product in clinical
-- The agreement will facilitate easier access to long-acting non-opioid pain control in over 1,800 member offices -- TAMPA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Sevāredent Sourcing Solutions, a Group Purchasing Organization (GPO) that creates a competitive advantage for like-minded dental
Award recognizes plastic surgeon for "Best Use of Opioid Alternatives" PARSIPPANY, N.J. --(BUSINESS WIRE)--Oct. 18, 2012-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that prominent Seattle -based plastic surgeon Richard A. Baxter, M.D., FACS was recognized by Outpatient Surgery
